Here's Why You Should Retain PacBio Stock in Your Portfolio for Now

Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent 2024 preliminary results and restructuring initiatives, is expected to contribute further. However, long purchasing cycles and business seasonality concerns persist.In the past six months, this Zacks Rank #3 (Hold) company’s shares have lost 8.1% against 4.8% growth of the industry. The S&P 500 Composite has also gained 9.4% in the said time frame.T ...